Prelude Capital Management, LLC Insulet Corp Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Insulet Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 3,140 shares of PODD stock, worth $826,950. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,140

Previous 3,140 -0.0%

Holding current value

$826,950

Previous $730,000 -0.0%

% of portfolio

0.05%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$180.69 - $239.01 $567,366 - $750,491	3,140 New	3,140 $730,000
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $674,497 - $1.17 Million	5,279 Added 154.58%	8,694 $1.89 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $528,198 - $993,389	3,415 New	3,415 $544,000
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $481,142 - $567,618	1,741 New	1,741 $555,000
Q3 2022 Nov 14, 2022	SELL	$224.6 - $281.45 $221,455 - $277,509	-986 Reduced 37.25%	1,661 $381,000
Q2 2022 Aug 15, 2022	BUY	$186.4 - $279.02 $51,073 - $76,451	274 Added 11.55%	2,647 $577,000
Q1 2022 May 16, 2022	BUY	$194.8 - $275.7 $462,260 - $654,236	2,373 New	2,373 $632,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $504,001 - $628,304	-1,974 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $1.9 Million - $2.24 Million	-7,290 Reduced 78.69%	1,974 $561,000
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $785,711 - $1.06 Million	3,484 Added 60.28%	9,264 $2.54 Million
Q1 2021 May 17, 2021	BUY	$235.95 - $293.05 $685,906 - $851,896	2,907 Added 101.18%	5,780 $1.51 Million
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $129,797 - $159,799	601 Added 26.45%	2,873 $734,000
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $14,248 - $17,507	74 Added 3.37%	2,272 $538,000
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $349,855 - $493,956	2,198 New	2,198 $427,000
Q1 2020 May 15, 2020	SELL	$130.01 - $216.44 $51,743 - $86,143	-398 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $57,634 - $74,028	398 New	398 $68,000
Q2 2019 Aug 14, 2019	SELL	$82.13 - $120.73 $1.13 Million - $1.66 Million	-13,779 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$72.44 - $101.87 $95,113 - $133,755	1,313 Added 10.53%	13,779 $1.31 Million
Q4 2018 Feb 14, 2019	BUY	$73.27 - $105.19 $148,591 - $213,325	2,028 Added 19.43%	12,466 $989,000
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $8,143 - $10,813	-100 Reduced 0.95%	10,438 $1.11 Million
Q1 2018 May 15, 2018	BUY	$68.49 - $87.2 $39,587 - $50,401	578 Added 5.8%	10,538 $913,000
Q4 2017 Feb 14, 2018	BUY	$55.67 - $71.8 $118,131 - $152,359	2,122 Added 27.07%	9,960 $687,000
Q3 2017 Nov 14, 2017	BUY	$49.68 - $59.46 $389,391 - $466,047	7,838	7,838 $432,000

Others Institutions Holding PODD

# of Institutions

687

Shares Held

62.6M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Insulet Corp Transaction History